Traduction de «billion among » (Néerlandais → Français) :

Pharmaceuticals: +69% to USD 1.6 billion Among factors contributing to the sharp rise in operating income were the markedly improved business performance and benefits from increased productivity as well as significantly lower exceptional charges.
Pharmaceuticals: +69% à USD 1,6 milliard Parmi les facteurs ayant contribué au bond du résultat opérationnel, il y a l'amélioration notable des ventes et les bénéfices provenant de la hausse de la productivité ainsi qu'une baisse importante des charges exceptionnelles.

Among investments in the 2010 period were USD 0.4 billion for acquisitions, including USD 0.3 billion for completion of the EBEWE Pharma transaction.
Parmi les investissements réalisés au premier trimestre 2010, il y a eu un montant d’USD 0,4 milliard pour des acquisitions, dont USD 0,3 milliard pour l’achèvement de la transaction EBEWE Pharma.

Vaccines and Diagnostics: USD 1.0 billion (–18%, –13% lc) A sharp reduction in deliveries of H5N1 avian pandemic flu vaccines compared to the 2008 period as well as lower sales of TBE (tick-borne encephalitis) vaccines in Europe were among reasons for the decline.
Vaccins et Diagnostic: USD 1,0 milliard (-18%, -13% en m. l). La baisse est due notamment à une chute des livraisons de vaccins contre la pandémie de grippe aviaire H5N1 comparé à 2008, ainsi qu’à une diminution des ventes de vaccins contre l’encéphalite à tiques en Europe.

Among the top six emerging markets (USD 1.2 billion, +22% cc), China, Brazil, India, Russia and South Korea maintained solid growth, but Turkey was hampered by cost-containment measures.
Les six grands marchés émergents (USD 1,2 milliard, +22% tcc), la Chine, le Brésil, l’Inde, la Russie et la Corée du Sud ont conservé une croissance solide, mais celle de la Turquie a été entravée par des mesures de maîtrise des coûts.

“This effort builds on the ongoing work of many partners committed to improving the lives of the 1 billion people affected by NTDs, most of whom are among the world’s poorest. “At Pfizer, we are working to combat NTDs by collaborating on drug development, broadening access to medicines and strengthening health care delivery for underserved people.
“At Pfizer, we are working to combat NTDs by collaborating on drug development, broadening access to medicines and strengthening health care delivery for underserved people.

Net income from continuing operations Among factors for the 12% decline in net income to USD 4.0 billion in the first half of 2009 were reduced contributions from the operating businesses and associated companies as well as higher financial charges.
Résultat net des activités poursuivies Une diminution des contributions provenant des activités opérationnelles et des sociétés associées ainsi qu’une hausse des charges financières ont fait partie des facteurs qui ont entraîné un repli de 12% du résultat net à USD 4,0 milliards au premier semestre 2009.